Prostate-Cancer Test Not Worth Risk, Panel Says - BusinessWeek

New York Times (blog)

Prostate-Cancer Test Not Worth Risk, Panel Says BusinessWeek “Many men are being subjected to the harms of treatment of prostate cancer that will never become symptomatic,” the panel wrote in the report released by the Annals of Internal Medicine. “There is convincing evidence that PSA-based screening for ... New Data Emerges on Harms of Prostate Cancer ScreeningNew York Times (blog) Men's Health Network and Veterans Health Council Oppose Final USPSTF ...MarketWatch (press release) Govt. Panel Scuttles Prostate Cancer Testing RecommendationsABC News all 297 news articles »

Relief of urinary symptoms is an underappreciated benefit of early stage ... - Science Codex

Relief of urinary symptoms is an underappreciated benefit of early stage ... Science Codex BOSTON – Treatment of early stage prostate cancer can also result in improved quality of life for a subgroup of men who suffer from lower urinary tract symptoms (LUTS), according to an abstract of a Beth Israel Deaconess Medical Center-led study ... and more »